Clinical trial
In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
NCT04920539 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 8, 2022
- Completion date
- December 30, 2025
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy, hiv infections